Synthetic antibodies for crystallization of structured RNA

Figure: Ribbon representation of FAB2-ΔC209 complex. The FAB2 heavy and light chains are colored in green and orange, respectively. The RNA backbone is shown as a blue ribbon and the RNA bases are shown as cones. Protein and RNA termini, FAB2 CDRs and RNA stems are labeled. Five cations (labeled 1-5) bound to RNA are shown as small magenta spheres. The insert shows a perpendicular view of the RNA-protein interface. CDRs H1, H2 and H3 for the heavy chain and L1, L2, L3 for the light chain are labeled. Two bulged-out uridines, U130 and U179, which are present at the P5a/P5c interface and involved in the interaction with FAB2, are shown in ball-and-stick mode and colored blue.

Anthony Kossiakoff group (University of Chicago) and collaborators

 

The groups of Kossiakoff, Piccarilli, and Koide provided a highlight on using Fabs to facilitate RNA structural work. Antibodies that bind protein antigens are indispensable in biochemical research and modern medicine, but knowledge of RNA-binding antibodies and their application in the ever-growing RNA field is lacking. The authors developed a robust approach using a synthetic phage-display library to select specific antigen-binding fragments (Fabs) targeting a large functional RNA. Using data collected at GM/CA-CAT, SBC-CAT, and SER-CAT, they solved the crystal structure of the first Fab-RNA complex at 1.95-Å resolution. The crystal structure reveals that the Fab achieves specific RNA binding on a shallow surface with complementarity-determining region (CDR) sequence diversity, length variability, and main-chain conformational plasticity (Fig. 12). The Fab-RNA interface also differs significantly from Fab-protein interfaces in amino acid composition and light-chain participation. The utility in phasing and in crystal-contact formation suggests that Fabs can serve as potentially valuable crystal chaperones for RNA. These findings yield valuable insights for engineering of Fabs as RNA-binding modules and facilitate further development of Fabs as possible therapeutic drugs and biochemical tools to explore RNA biology.

 

Citation:
Ye, J-D, Tereshko, V, Frederiksen, JK, Koide, A, Fellouse, FA, Sidhu, SS, Koide, S, Kossiakoff, AA, Piccirilli, JA, Synthetic antibodies for specific recognition and crystallization of structured RNA, Proc. Natl. Acad. Sci. USA 105 (1), 82-87 (2008). DOI: 10.1073/pnas.0709082105.

 

 


GM/CA @ APS Sponsors: National Institute of General Medical Sciences (NIGMS) and National Cancer Institute (NCI) of the National Institutes of Health (NIH).

  APS is an Office of Science User Facility operated for the U.S. Department of Energy by Argonne National Laboratory

  UChicago Argonne LLC | Privacy & Security Notice | Contact Us | A-Z Index | Search